About | Free Trial

Last Update

2016-07-13T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Robert Ward?

Dr. Robert Ward S.

President and Chief Executive Officer

ExThera Medical Corporation

Direct Phone: (510) ***-****       

Email: r***@***.com

ExThera Medical Corporation

813 Heinz Avenue

Berkeley, California 94710

United States

Company Description

Privately held ExThera Medical, based in Berkeley, Calif., is targeting the clinical treatment of blood-borne diseases including bacteremia and sepsis, as well as the removal of harmful substances present in banked human blood. more

Find other employees at this company (4)

Background Information

Employment History

Partner

TechRegen

Chairman

Emergence Venture Partners LLC

Contracting Specialist

TechnologieS Inc

Video Producer

Columbia University

Video Producer

Media Law and Policy

Vice President

Pinacor Inc.

President MERCOR Division

Thoratec Corporation

Vice President

MicroAge , Inc.

Affiliations

Board Member
Surfaces

Founder
The Polymer Technology Group Inc

President and Chief Executive Officer
DSM N.V.

Founder
PTG

Education


engineering management and polymer science
Northeastern University

B.S.
chemical engineering
University of Massachusetts

Doctorate
Humane Letters
University of Massachusetts

Masters Certificate
Government Contracting
George Washington University

honorary Ph.D.

University of Massachusetts

honorary doctorate degree

University of Massachusetts Lowell

Web References (164 Total References)


medtech incubator, Emergence Venture Partners, LLC. Leadership

www.emergence-llc.com [cached]

Robert S. Ward, Ph.D. Chairman

Bob Ward, a chemical engineer and well-known expert in biomedical polymer science, is Chairman of Emergence Venture Partners LLC, President and CEO of ExThera Medical, and the former President and Chief Executive of DSM Biomedical in Berkeley, California, a biomaterials and medical device company he founded in 1989 (Polymer Technology Group, "PTG").
Bob has 40 years of experience in the development and manufacturing of Class III medical devices, and R&D/manufacturing of novel biomaterials for critical applications. Materials and components developed and manufactured under his direction have been used in hundreds of devices and prosthetic implants.
He is a frequent contributor to the technical literature and the inventor of many widely used biomaterials and surface modification technologies. In 2003 he was awarded the "Technology Innovation and Development Award" from the Society for Biomaterials. In 2004he was named one of MD&DI's "100 Most Notable People" in the medical device industry. In 2006 he received the "Excellence in Surface Science Award" from The Surfaces in Biomaterials Foundation. In 2012 he was awarded an honorary Ph.D. from the University of Massachusetts. Earlier in his career, he worked for seven years for Avco Medical Products, and 10 years for Thoratec before founding PTG. Bob studied engineering management and polymer science at Northeastern University and he has a B.S. in chemical engineering from the University of Massachusetts and a Doctorate in Humane Letters from the University of Massachusetts.


ExThera Medical's outstanding leadership

www.extheramedical.com [cached]

Robert S. Ward, Ph.D. (h)

President & Chief Executive Officer
Bob Ward, a chemical engineer and well-known expert in biomedical polymer science, is Chairman of Emergence Venture Partners LLC, President and CEO of ExThera Medical, and the former President and Chief Executive of DSM Biomedical in Berkeley, California, a biomaterials and medical device company he founded in 1989 (asThe Polymer Technology Group). Dr. Ward has nearly 40 years of related experience. He is a frequent contributor to the technical literature and the inventor of many widely-used biomaterials and surface modification technologies. In 2003 he was awarded the Technology Innovation and Development Award from the Society for Biomaterials. In 2004 he was named one of MD&DI's 100 most notable people in the medical device industry. In 2006 he received the Excellence in Surface Science award from The Surfaces in Biomaterials Foundation. In 2012 he was awarded an honorary Ph.D. from the University of Massachusetts. Bob worked for seven years for Avco Medical Products, and 10 years for Thoratec before founding PTG. He studied Engineering Management and polymer science at Northeastern University, and he has a BS in Chemical Engineering from the University of Massachusetts.


Emergence

www.emergence-llc.com [cached]

Robert S. ("Bob") Ward receives honorary doctorate degree from University of Massachusetts Lowell

Management
Robert S. Ward, Ph.D. Chairman
Bob Ward, a chemical engineer and well-known expert in biomedical polymer science, is Chairman of Emergence Venture Partners LLC, President and CEO of ExThera Medical, and the former President and Chief Executive of DSM Biomedical in Berkeley, California, a biomaterials and medical device company he founded in 1989 (Polymer Technology Group, "PTG").
Bob has 40 years of experience in the development and manufacturing of Class III medical devices, and R&D/manufacturing of novel biomaterials for critical applications. Materials and components developed and manufactured under his direction have been used in hundreds of devices and prosthetic implants. -
He is a frequent contributor to the technical literature and the inventor of many widely used biomaterials and surface modification technologies. In 2003 he was awarded the "Technology Innovation and Development Award" from the Society for Biomaterials. In 2004he was named one of MD&DI's "100 Most Notable People" in the medical device industry. In 2006 he received the "Excellence in Surface Science Award" from The Surfaces in Biomaterials Foundation. In 2012 he was awarded an honorary Ph.D. from the University of Massachusetts. Earlier in his career, he worked for seven years for Avco Medical Products, and 10 years for Thoratec before founding PTG. Bob studied engineering management and polymer science at Northeastern University and he has a B.S. in chemical engineering from the University of Massachusetts and a Doctorate in Humane Letters from the University of Massachusetts.


ExThera Medical Closes Financing Led by Fresenius Medical Care Ventures to Support Commercialization of Innovative Technology to Remove Pathogens From Whole Blood | Business Wire

feeds.businesswire.com [cached]

"ExThera's vision is to make life-threatening bloodstream infections unheard of in the future by providing clinicians with a broad-spectrum therapeutic option that allows treatment to begin quickly - even before pathogen identification," said Robert Ward, CEO of ExThera Medical.


Venture Capital Access Online | Venture Capital News

www.vcaonline.com [cached]

?ExThera?s vision is to make life-threatening bloodstream infections unheard of in the future by providing clinicians with a broad-spectrum therapeutic option that allows treatment to begin quickly ? even before pathogen identification,? said Robert Ward, CEO of ExThera Medical. ?With mortality rates as high as 50 percent for certain bloodstream infections1, the continued emergence of drug-resistant pathogens, and fewer anti-infective drugs in development, we see a critical need to address this growing global health issue with safe, accessible and cost-effective solutions.

Similar Profiles

Other People with this Name

Other people with the name Ward

David Ward
The Daimler Group Inc

Jeremy Ward
Excelian Limited

Jim Ward
Kingsbridge Capital Partners

Celeste Ward
Immaculate Heart Catholic Church

Catherine Ward
SaleBoards LTD

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory